The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 06, 2018

Filed:

Jan. 10, 2014
Applicants:

Baylor Research Institute, Dallas, TX (US);

Institut National DE LA Sante ET DE LA Recherche Medicale (Inserm), Paris, FR;

Inventors:

Helene Dutartre, Dallas, TX (US);

Yves Levy, Paris, FR;

Jacques Banchereau, Montclair, NJ (US);

Gerard Zurawski, Midlothian, TX (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 39/00 (2006.01); C07K 16/28 (2006.01); A61P 37/04 (2006.01); C12N 5/0784 (2010.01); A61K 39/29 (2006.01); A61K 39/12 (2006.01); C07K 14/005 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0639 (2013.01); A61K 39/12 (2013.01); A61K 39/29 (2013.01); C07K 14/005 (2013.01); C07K 16/2851 (2013.01); C07K 16/2878 (2013.01); A61K 2039/6056 (2013.01); C07K 2319/00 (2013.01); C07K 2319/33 (2013.01); C12N 2770/24222 (2013.01); C12N 2770/24234 (2013.01);
Abstract

Compositions comprising viral antigens and antigenic peptides corresponding to or derived from Hepatitis C virus (HCV) proteins or fragments thereof, fused to heavy and/or light chain of antibodies, or fragments thereof specific for dendritic cells (DCs) are described herein. Included herein are immunostimulatory compositions (HCV vaccines, HCV antigen presenting dendritic cells, etc.) and methods for increasing effectiveness of HCV antigen presentation by an antigen presenting cell, for a treatment, a prophylaxis or a combination thereof against hepatitis C in a human subject, and methods of providing immunostimulation by activation of one or more dendritic cells, methods to treat or prevent hepatitis C.


Find Patent Forward Citations

Loading…